165 0 Kommentare Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer - Seite 2

“Every year the lives of thousands of families are disrupted by the announcement of a pancreatic cancer for which no one is prepared! Since 2016, Espoir Pancréas has been fighting for early detection of pancreatic cancer. We truly hope that in the future Artificial Intelligence solutions will offer improved diagnosis and prognosis for patients suffering from these cancers.”
Philippe François-Steininger, Chairman of the association Espoir Pancréas

Connections with the project’s clinical partners are already in progress and certain French and international partnerships are already under discussion. Furthermore, a large database has already been constituted.

This financial support will enable the acceleration of the development of the solution and the recognition provides great incentive for the project team.

“BPI’s financial support is a great acknowledgement of the quality of Guerbet’s work in the field of Artificial Intelligence at the service of healthcare. This support will enable the development of the project to be accelerated and give it the dimension necessary to develop a commercial product by 2025. We are convinced that these promising Artificial Intelligence solutions will contribute to the improvement of the diagnosis of cancers with a high mortality rate. Guerbet is thus demonstrating once again the ability to provide professionals with a major innovation for the benefit of patients.”
François Nicolas, Vice-President in charge of R&D at Guerbet

About France 2030

The France 2030 investment plan:

Translates a dual ambition: to sustainably transform key sectors of our economy (energy, automobile, aeronautics and space) by technological innovation, and position France not only as an actor but as a leader in tomorrow’s world. From fundamental research to the emergence of an idea until the production of a new product or service, France 2030 supports the entire life cycle from innovation until its industrialization.
Is unique in its scope: €54 billion will be invested so that our companies, our universities and our research organizations fully succeed with their transitions in these strategic branches. What is at stake is to enable them to respond in a competitive manner to the ecological and attractiveness challenges of tomorrow’s world and unveil the future champions of our industries of excellence. France 2030 is defined by two transverse objectives, consisting of devoting 50% of its expenditure to decarbonization of the economy and 50% to emerging actors full of innovation without expenditure unfavorable to the environment (in the sense of the Do No Significant Harm principle).
Is implemented collectively: thought through and deployed in conjunction with local and European economic and academic actors to determine the strategic guidelines and flagship actions thereof. Project innovators are invited to submit their dossier via open, demanding and selective procedures to benefit from State accompaniment.
Is coordinated by the General Secretariat for investment on behalf of the Prime Minister and implemented by the Ecological Transition Agency (ADEME), the National Research Agency (ANR), Bpifrance and the Caisse des Dépôts et Consignations (CDC).